ATM Variants in Radiotherapy Patients

Plain-language summary

This study examines whether variants in the ATM gene are linked to treatment-related side effects (radiation toxicity) in patients receiving radiotherapy. It enrolled patients with an indication for radiotherapy who agreed to give a blood sample. The research was conducted as a study with no assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

University of Wisconsin, Madison

Start date

12/1/2007

Estimated completion

1/1/2013

Countries

United States

Related genes

Locations

• Madison, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Indication for radiotherapy.
* Ability or desire to donate a blood sample and be followed closely for radiation toxicities